Julieta Fernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julieta Fernández has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Federico Sisti
Instituto de Biotecnologia y Biologia Molecular
18 shared publications - Daniela Hozbor
Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CCT-CONICET La Plata, La Plata, Argentina
10 shared publications - Frederick Heath Damron
Department of Microbiology, Immunology, and Cell Biology, School of Medicine, West Virginia University
3 shared publications Nicolás Ambrosis
CCT La Plata. CONICET. Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, UNLP, Instituto de Biotecnología y Biología Molecular
3 shared publicationsAdriana Casabuono
CIHIDECAR, Departamento de Química Orgánica, Facultad de Cs Exactas y Naturales, Universidad de Buenos Aires, 1428 Bs. As., Argentina
2 shared publicationsAlicia Couto
CIHIDECAR, Departamento de Química Orgánica, Facultad de Cs Exactas y Naturales, Universidad de Buenos Aires, 1428 Bs. As., Argentina
2 shared publications
Latest Publications
- Open Access
- 12 November 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (11) , e0213625
Microbes without borders: uniting societies for climate action
The climate crisis is one of the greatest challenges of our time, yet the role of microorganisms remains underrecognized in climate science and policy. Microbes are highly sensitive to environmental change and regulate essential biogeochemical processes, while also offering solutions for reducing emissions, restoring ecosystems, and enhancing resilience. Microbiology societies from five continents recently convened in Washington, DC, for the inaugural Global Strategy Meeting on Microbes and Climate Change. The gathering launched a global alliance to position microbial science as a pillar of climate action and identified four priorities: building a coalition, embedding microbes in climate frameworks, transforming communication, and advancing real-world demonstration projects. This initiative marks the beginning of coordinated global action to harness microbial life for climate solutions.
- 12 November 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (11) , e0213625
Open AccessMicrobes without borders: uniting societies for climate action
The climate crisis is one of the greatest challenges of our time, yet the role of microorganisms remains underrecognized in climate science and policy. Microbes are highly sensitive to environmental change and regulate essential biogeochemical processes, while also offering solutions for reducing emissions, restoring ecosystems, and enhancing resilience. Microbiology societies from five continents recently convened in Washington, DC, for the inaugural Global Strategy Meeting on Microbes and Climate Change. The gathering launched a global alliance to position microbial science as a pillar of climate action and identified four priorities: building a coalition, embedding microbes in climate frameworks, transforming communication, and advancing real-world demonstration projects. This initiative marks the beginning of coordinated global action to harness microbial life for climate solutions.
- Open Access
- 17 April 2025
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 207 (4) , e0044524
Interplay of virulence factors and signaling molecules: albumin and calcium-mediated biofilm regulation in Bordetella bronchiseptica
Bordetella bronchiseptica, a respiratory pathogen capable of infecting various mammals, including humans, is associated with chronic infections. B. bronchiseptica can form biofilm-like structures in vivo , providing tolerance against environmental stresses. Recent studies have highlighted the role of cyclic diguanylate monophosphate (c-di-GMP) in this process in vitro : elevated c-di-GMP levels stimulate biofilm formation, whereas phosphodiesterase (PDE) activation reduces biofilms. Respiratory secretions, which contain albumin and calcium at higher concentrations than standard growth media, promote an increase in the amount and extracellular localization of the adenylate cyclase toxin (ACT), an important virulence factor of Bordetella spp . Secreted ACT, present in the extracellular medium or attached to the outer membrane, inhibits biofilm formation. Based on these observations, we hypothesized that serum albumin and calcium together inhibit biofilm formation and explored the potential role of c-di-GMP in this process. Our findings suggest that serum albumin and calcium inhibit B. bronchiseptica biofilm formation through two potentially independent mechanisms: one involving ACT secretion and another promoting c-di-GMP degradation. In the presence of albumin and calcium, intracellular levels of c-di-GMP were reduced, and specific PDEs appear to be involved in this process. In addition, albumin and calcium stimulated the secretion of the adhesin BrtA. This study contributes to the understanding of the mechanisms governing B. bronchiseptica biofilm formation and its modulation by host factors. IMPORTANCE: Bordetella bronchiseptica , a respiratory pathogen capable of infecting various mammals, forms biofilms that enhance its ability to withstand environmental stresses. This study reveals that host-derived factors, specifically serum albumin and calcium, inhibit biofilm formation through two independent mechanisms: increasing adenylate cyclase toxin secretion and promoting the degradation of cyclic diguanylate monophosphate (c-di-GMP), a key biofilm regulator. These findings provide insights into how host conditions influence B. bronchiseptica biofilm dynamics, shedding light on the complex interactions between pathogen and host that contribute to infection persistence. Understanding these mechanisms may inform strategies to mitigate chronic infections caused by B. bronchiseptica .
- 17 April 2025
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 207 (4) , e0044524
Open AccessInterplay of virulence factors and signaling molecules: albumin and calcium-mediated biofilm regulation in Bordetella bronchiseptica
Bordetella bronchiseptica, a respiratory pathogen capable of infecting various mammals, including humans, is associated with chronic infections. B. bronchiseptica can form biofilm-like structures in vivo , providing tolerance against environmental stresses. Recent studies have highlighted the role of cyclic diguanylate monophosphate (c-di-GMP) in this process in vitro : elevated c-di-GMP levels stimulate biofilm formation, whereas phosphodiesterase (PDE) activation reduces biofilms. Respiratory secretions, which contain albumin and calcium at higher concentrations than standard growth media, promote an increase in the amount and extracellular localization of the adenylate cyclase toxin (ACT), an important virulence factor of Bordetella spp . Secreted ACT, present in the extracellular medium or attached to the outer membrane, inhibits biofilm formation. Based on these observations, we hypothesized that serum albumin and calcium together inhibit biofilm formation and explored the potential role of c-di-GMP in this process. Our findings suggest that serum albumin and calcium inhibit B. bronchiseptica biofilm formation through two potentially independent mechanisms: one involving ACT secretion and another promoting c-di-GMP degradation. In the presence of albumin and calcium, intracellular levels of c-di-GMP were reduced, and specific PDEs appear to be involved in this process. In addition, albumin and calcium stimulated the secretion of the adhesin BrtA. This study contributes to the understanding of the mechanisms governing B. bronchiseptica biofilm formation and its modulation by host factors. IMPORTANCE: Bordetella bronchiseptica , a respiratory pathogen capable of infecting various mammals, forms biofilms that enhance its ability to withstand environmental stresses. This study reveals that host-derived factors, specifically serum albumin and calcium, inhibit biofilm formation through two independent mechanisms: increasing adenylate cyclase toxin secretion and promoting the degradation of cyclic diguanylate monophosphate (c-di-GMP), a key biofilm regulator. These findings provide insights into how host conditions influence B. bronchiseptica biofilm dynamics, shedding light on the complex interactions between pathogen and host that contribute to infection persistence. Understanding these mechanisms may inform strategies to mitigate chronic infections caused by B. bronchiseptica .
- Open Access
- 5 November 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (11) , e0079424
BvgR is important for virulence-related phenotypes in Bordetella bronchiseptica
Bordetella bronchiseptica is a pathogenic bacterium that causes respiratory infections in mammals. Adhesins, toxins, and secretion systems necessary for infection are regulated by the two-component system BvgAS. When the BvgAS system is inactive, there is no transcription of virulence-activated genes, and virulence-repressed genes ( vrg ) are expressed. The regulation of some vrgs in B. bronchiseptica is dependent upon the virulence-activated gene bvgR . Although having a regulatory role, no DNA-binding domain is described for BvgR. Instead, it contains an EAL domain, usually found in cyclic-di-GMP (c-di-GMP)-specific phosphodiesterases. c-di-GMP is a bacterial second messenger that regulates multiple phenotypes in bacteria, including B. bronchiseptica . The current study aimed to deepen our knowledge about BvgR. We employed RNA-seq analysis to define the BvgR regulon, and then we investigated the phenotypes in which BvgR regulation might be involved such as biofilm formation, cytotoxicity, and virulence. Our result revealed that BvgR inhibits biofilm formation and flagellin expression in virulent phase. Although BvgR has long been considered a repressor protein, our results show that it also upregulates almost 100 genes. This regulation is likely indirect, as BvgR lacks a DNA-binding domain. Notably, among the upregulated genes, we identified 15 associated with the type three secretion system. Consistent with these findings, a B. bronchiseptica strain deficient in bvgR was less cytotoxic than the wild-type strain, elicited a milder immune response, and was less able to persist in the lower respiratory tract of mice. IMPORTANCE: Bordetella bronchiseptica is a harmful bacterium responsible for respiratory infections in mammals. Its ability to cause disease is tightly regulated by a system called BvgAS. In this study, we focused on understanding the role of a specific gene called bvgR in regulating B. bronchiseptica ’s virulence factors. Our findings revealed that BvgR, previously thought to primarily repress gene expression, actually plays a complex role in both activating and inhibiting various genes involved in bacterial virulence. This newfound understanding sheds light on the intricate mechanisms underlying B. bronchiseptica ’s ability to cause infections, providing valuable insights for developing strategies to combat these infections in humans and animals.
- 5 November 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (11) , e0079424
Open AccessBvgR is important for virulence-related phenotypes in Bordetella bronchiseptica
Bordetella bronchiseptica is a pathogenic bacterium that causes respiratory infections in mammals. Adhesins, toxins, and secretion systems necessary for infection are regulated by the two-component system BvgAS. When the BvgAS system is inactive, there is no transcription of virulence-activated genes, and virulence-repressed genes ( vrg ) are expressed. The regulation of some vrgs in B. bronchiseptica is dependent upon the virulence-activated gene bvgR . Although having a regulatory role, no DNA-binding domain is described for BvgR. Instead, it contains an EAL domain, usually found in cyclic-di-GMP (c-di-GMP)-specific phosphodiesterases. c-di-GMP is a bacterial second messenger that regulates multiple phenotypes in bacteria, including B. bronchiseptica . The current study aimed to deepen our knowledge about BvgR. We employed RNA-seq analysis to define the BvgR regulon, and then we investigated the phenotypes in which BvgR regulation might be involved such as biofilm formation, cytotoxicity, and virulence. Our result revealed that BvgR inhibits biofilm formation and flagellin expression in virulent phase. Although BvgR has long been considered a repressor protein, our results show that it also upregulates almost 100 genes. This regulation is likely indirect, as BvgR lacks a DNA-binding domain. Notably, among the upregulated genes, we identified 15 associated with the type three secretion system. Consistent with these findings, a B. bronchiseptica strain deficient in bvgR was less cytotoxic than the wild-type strain, elicited a milder immune response, and was less able to persist in the lower respiratory tract of mice. IMPORTANCE: Bordetella bronchiseptica is a harmful bacterium responsible for respiratory infections in mammals. Its ability to cause disease is tightly regulated by a system called BvgAS. In this study, we focused on understanding the role of a specific gene called bvgR in regulating B. bronchiseptica ’s virulence factors. Our findings revealed that BvgR, previously thought to primarily repress gene expression, actually plays a complex role in both activating and inhibiting various genes involved in bacterial virulence. This newfound understanding sheds light on the intricate mechanisms underlying B. bronchiseptica ’s ability to cause infections, providing valuable insights for developing strategies to combat these infections in humans and animals.
- Open Access
Interplay of Virulence Factors and Signaling Molecules: Albumin and Calcium-Mediated Biofilm Regulation in Bordetella bronchiseptica
Bordetella bronchiseptica , a respiratory pathogen capable of infecting various mammals, including humans, is associated with chronic infections, contrasting with the acute infections caused by Bordetella pertussis . Both pathogens can form biofilm-like structures in vivo , providing tolerance against environmental stresses. Biofilm formation by B. bronchiseptica is regulated by the BvgAS two-component system, with intermediate concentrations of certain modulators inducing a phase favoring biofilm formation. Recent studies have highlighted the role of cyclic diguanylate monophosphate (c-di-GMP) in this process: elevated c-di-GMP levels stimulate biofilm formation, whereas phosphodiesterase (PDE) activation reduces biofilms. Respiratory secretions, which contain albumin and calcium at higher concentrations than standard growth media, promote an increase in the amount and extracellular localization of the adenylate cyclase toxin (ACT), an important Bordetella spp . virulence factor. Secreted ACT present in the extracellular media or attached to the outer membrane inhibits biofilm formation. Based on these observations, we hypothesized that serum albumin and calcium together inhibit biofilm formation and explored the potential role of c-di-GMP in this process. Our findings demonstrate that serum albumin and calcium inhibit B. bronchiseptica biofilm formation by two apparently independent mechanisms, increasing AC secretion and inducing c-di-GMP degradation. This study contributes to the understanding of the mechanisms governing B. bronchiseptica biofilm formation and its modulation by host factors.
Open AccessInterplay of Virulence Factors and Signaling Molecules: Albumin and Calcium-Mediated Biofilm Regulation in Bordetella bronchiseptica
Bordetella bronchiseptica , a respiratory pathogen capable of infecting various mammals, including humans, is associated with chronic infections, contrasting with the acute infections caused by Bordetella pertussis . Both pathogens can form biofilm-like structures in vivo , providing tolerance against environmental stresses. Biofilm formation by B. bronchiseptica is regulated by the BvgAS two-component system, with intermediate concentrations of certain modulators inducing a phase favoring biofilm formation. Recent studies have highlighted the role of cyclic diguanylate monophosphate (c-di-GMP) in this process: elevated c-di-GMP levels stimulate biofilm formation, whereas phosphodiesterase (PDE) activation reduces biofilms. Respiratory secretions, which contain albumin and calcium at higher concentrations than standard growth media, promote an increase in the amount and extracellular localization of the adenylate cyclase toxin (ACT), an important Bordetella spp . virulence factor. Secreted ACT present in the extracellular media or attached to the outer membrane inhibits biofilm formation. Based on these observations, we hypothesized that serum albumin and calcium together inhibit biofilm formation and explored the potential role of c-di-GMP in this process. Our findings demonstrate that serum albumin and calcium inhibit B. bronchiseptica biofilm formation by two apparently independent mechanisms, increasing AC secretion and inducing c-di-GMP degradation. This study contributes to the understanding of the mechanisms governing B. bronchiseptica biofilm formation and its modulation by host factors.
- Open Access
- 17 January 2024
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 13 (1) , e0099723
Draft genome sequence of Mannheimia haemolytica strain Oliden, isolated from a calf lung infection in Argentina
We present the draft genome sequence of a Mannheimia haemolytica strain isolated from a postmortem lung lesion from a calf diagnosed with bovine respiratory disease. The genome sequence was 2,749,707-bp long with 2,909 putative protein-encoding genes.
- 17 January 2024
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 13 (1) , e0099723
Open AccessDraft genome sequence of Mannheimia haemolytica strain Oliden, isolated from a calf lung infection in Argentina
We present the draft genome sequence of a Mannheimia haemolytica strain isolated from a postmortem lung lesion from a calf diagnosed with bovine respiratory disease. The genome sequence was 2,749,707-bp long with 2,909 putative protein-encoding genes.
- Open Access
- 2 May 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-15
Bordetella bronchiseptica diguanylate cyclase BdcB inhibits the type three secretion system and impacts the immune response
Bordetella bronchiseptica is a gram-negative bacterium that causes respiratory diseases in different animals, including mice, making B. bronchiseptica the gold-standard model to investigate host–pathogen interaction at the molecular level. B. bronchiseptica utilizes many different mechanisms to precisely regulate the expression of virulence factors. Cyclic di-GMP is a second messenger synthesized by diguanylate cyclases and degraded by phosphodiesterases that regulates the expression of multiple virulence factors including biofilm formation. As in other bacteria, we have previously shown that c-di-GMP regulates motility and biofilm formation in B. bronchiseptica. This work describes the diguanylate cyclase BdcB (Bordetelladiguanylate cyclase B) as an active diguanylate cyclase that promotes biofilm formation and inhibits motility in B. bronchiseptica. The absence of BdcB increased macrophage cytotoxicity in vitro and induced a greater production of TNF-α, IL-6, and IL-10 by macrophages. Our study reveals that BdcB regulates the expression of components of T3SS, an important virulence factor of B. bronchiseptica. The Bb∆bdcB mutant presented increased expression of T3SS-mediated toxins such as bteA, responsible for cytotoxicity. Our in vivo results revealed that albeit the absence of bdcB did not affect the ability of B. bronchiseptica to infect and colonize the respiratory tract of mice, mice infected with Bb∆bdcB presented a significantly higher pro-inflammatory response than those infected with wild type B. bronchiseptica.
- 2 May 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-15
Open AccessBordetella bronchiseptica diguanylate cyclase BdcB inhibits the type three secretion system and impacts the immune response
Bordetella bronchiseptica is a gram-negative bacterium that causes respiratory diseases in different animals, including mice, making B. bronchiseptica the gold-standard model to investigate host–pathogen interaction at the molecular level. B. bronchiseptica utilizes many different mechanisms to precisely regulate the expression of virulence factors. Cyclic di-GMP is a second messenger synthesized by diguanylate cyclases and degraded by phosphodiesterases that regulates the expression of multiple virulence factors including biofilm formation. As in other bacteria, we have previously shown that c-di-GMP regulates motility and biofilm formation in B. bronchiseptica. This work describes the diguanylate cyclase BdcB (Bordetelladiguanylate cyclase B) as an active diguanylate cyclase that promotes biofilm formation and inhibits motility in B. bronchiseptica. The absence of BdcB increased macrophage cytotoxicity in vitro and induced a greater production of TNF-α, IL-6, and IL-10 by macrophages. Our study reveals that BdcB regulates the expression of components of T3SS, an important virulence factor of B. bronchiseptica. The Bb∆bdcB mutant presented increased expression of T3SS-mediated toxins such as bteA, responsible for cytotoxicity. Our in vivo results revealed that albeit the absence of bdcB did not affect the ability of B. bronchiseptica to infect and colonize the respiratory tract of mice, mice infected with Bb∆bdcB presented a significantly higher pro-inflammatory response than those infected with wild type B. bronchiseptica.
- Open Access
- 20 December 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (6) , e0273422
Cyclic di-GMP Signaling Links Biofilm Formation and Mn(II) Oxidation in Pseudomonas resinovorans
The presence of Mn(II) in groundwater, a common source of drinking water, is a cause of water quality impairment, interfering with its disinfection, causing operation problems, and affecting human health. Purification of groundwater containing Mn(II) plays an important role in environmental and social safety.
- 20 December 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (6) , e0273422
Open AccessCyclic di-GMP Signaling Links Biofilm Formation and Mn(II) Oxidation in Pseudomonas resinovorans
The presence of Mn(II) in groundwater, a common source of drinking water, is a cause of water quality impairment, interfering with its disinfection, causing operation problems, and affecting human health. Purification of groundwater containing Mn(II) plays an important role in environmental and social safety.
- 16 June 2022
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 90 (6) , e0010722
Cyclic di-GMP Regulates the Type III Secretion System and Virulence in Bordetella bronchiseptica
The second messenger cyclic di-GMP (c-di-GMP) is a ubiquitous molecule in bacteria that regulates diverse phenotypes. Among them, motility and biofilm formation are the most studied.
- 16 June 2022
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 90 (6) , e0010722
Cyclic di-GMP Regulates the Type III Secretion System and Virulence in Bordetella bronchiseptica
The second messenger cyclic di-GMP (c-di-GMP) is a ubiquitous molecule in bacteria that regulates diverse phenotypes. Among them, motility and biofilm formation are the most studied.
- 24 April 2021
- Published by Springer Nature in Marine Biology
- Vol. 168 (5) , 1-13
Phenotypic plasticity in Pygoscelis adeliae physiology and immunity under anthropogenic pressure: a proteomic and biochemical scenario
- 24 April 2021
- Published by Springer Nature in Marine Biology
- Vol. 168 (5) , 1-13
Phenotypic plasticity in Pygoscelis adeliae physiology and immunity under anthropogenic pressure: a proteomic and biochemical scenario
- Open Access
- 9 November 2020
- Published by Wiley in Current Protocols in Microbiology
- Vol. 59 (1) , e125
Counter‐Selection Method for Markerless Allelic Exchange in Bordetella bronchiseptica Based on sacB Gene From Bacillus subtilis
Bordetella bronchiseptica is a gram‐negative bacterium that causes respiratory tract infections. It is a natural pathogen of a wide variety of mammals, including some used as laboratory models. This makes B. bronchiseptica an ideal organism to study pathogen–host interactions in order to unveil molecular mechanisms behind pathogenic processes. Even though genetic engineering is an essential tool in this area, there are just a few reports about genome manipulation techniques in this organism. In this article we describe an allelic exchange protocol based on double crossover recombination facilitated by the Bacillus subtilis sacB gene that can be applied for partial or complete gene knockouts, single‐nucleotide mutations, or even introduction of coding sequences for transcriptional fusions. In contrast to previously employed techniques, this protocol renders genetically manipulated chromosomes without foreign DNA and enables the construction of successive genome manipulation using the same vector backbone. The entire procedure has been developed for fast and reliable manipulations with a total duration of 2 weeks. © 2020 Wiley Periodicals LLC.Basic Protocol 1: Setting up strainsBasic Protocol 2: Homologous recombination (first crossing‐over)Alternate Protocol: B. bronchiseptica electroporationBasic Protocol 3: Screening for sucrose‐sensitive clonesBasic Protocol 4: Homologous recombination (second crossing‐over)Basic Protocol 5: PCR screening of putative marker‐exchange mutantsSupport Protocol: Electrocompetent cell preparation
- 9 November 2020
- Published by Wiley in Current Protocols in Microbiology
- Vol. 59 (1) , e125
Open AccessCounter‐Selection Method for Markerless Allelic Exchange in Bordetella bronchiseptica Based on sacB Gene From Bacillus subtilis
Bordetella bronchiseptica is a gram‐negative bacterium that causes respiratory tract infections. It is a natural pathogen of a wide variety of mammals, including some used as laboratory models. This makes B. bronchiseptica an ideal organism to study pathogen–host interactions in order to unveil molecular mechanisms behind pathogenic processes. Even though genetic engineering is an essential tool in this area, there are just a few reports about genome manipulation techniques in this organism. In this article we describe an allelic exchange protocol based on double crossover recombination facilitated by the Bacillus subtilis sacB gene that can be applied for partial or complete gene knockouts, single‐nucleotide mutations, or even introduction of coding sequences for transcriptional fusions. In contrast to previously employed techniques, this protocol renders genetically manipulated chromosomes without foreign DNA and enables the construction of successive genome manipulation using the same vector backbone. The entire procedure has been developed for fast and reliable manipulations with a total duration of 2 weeks. © 2020 Wiley Periodicals LLC.Basic Protocol 1: Setting up strainsBasic Protocol 2: Homologous recombination (first crossing‐over)Alternate Protocol: B. bronchiseptica electroporationBasic Protocol 3: Screening for sucrose‐sensitive clonesBasic Protocol 4: Homologous recombination (second crossing‐over)Basic Protocol 5: PCR screening of putative marker‐exchange mutantsSupport Protocol: Electrocompetent cell preparation